Defence Therapeutics Inc. (DTCFF)
Market Closed
10 Aug, 20:00
OTC PINK 
$
0. 27
-0.03
-9.8695%
$
20.08M Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
0 Eps
$ 0.3
Previous Close Want to track DTCFF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Defence Therapeutics Inc. (DTCFF) Statistics
Valuation metrics
Market Cap 20.08M
Enterprise value 28.93M
Trailing P/E (ttm) -3.58
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 4.36
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.71K
Average volume (90 days) 6.15K
Price summary
52-Week low 0.25
52-Week high 0.78
Beta -
50-Day moving average 0.31
200-Day moving average 0.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:32
Last split Date 17 May 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.67%
Return on equity -16.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 3.37%
Book value per share (mrq) 0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
